ARMISTICE CAPITAL LLC 13D and 13G filings for InVivo Therapeutics Holdings Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:53 pm Sale | 2023-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | ARMISTICE CAPITAL LLC | 163,100 4.990% | -81,899 (-33.43%) | Filing |
| 2023-02-14 1:13 pm Purchase | 2022-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | ARMISTICE CAPITAL LLC | 244,999 9.990% | 244,999 (New Position) | Filing |